NCT04025944 Real World Study of Chronic Viral Hepatitis
| NCT ID | NCT04025944 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Huashan Hospital |
| Condition | Hepatitis, Chronic |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2019-07-20 |
| Primary Completion | 2024-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2019-07-20 with a primary completion date of 2024-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is aimed to collect and analyze clinical data of patients with chronic viral hepatitis in the real world, to investigate the long-term outcome of these patients and to optimize treatment options based on these data.
Eligibility Criteria
Inclusion Criteria: 1. Informed consent of patients. 2. Evidence of persistent virus infection for greater than six months \[hepatitis C virus(HCV) RNA positive, hepatitis B surface antigen(HBsAg) or hepatitis B virus(HBV) DNA positive\] Exclusion Criteria: 1. Serious psychiatric history, especially depression. * Severe mental illness is defined as major depression or psychosis, suicide attempts, hospitalization due to mental illness or a period of disability due to mental illness. 2. Patients with serious diseases of heart, lung, kidney, brain, blood and other important organs. 3. Patients with malignant tumors (excluding those cured).
Contact & Investigator
Wenhong Zhang, Professor
STUDY CHAIR
Huashan Hospital
Frequently Asked Questions
Who can join the NCT04025944 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Hepatitis, Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04025944 currently recruiting?
Yes, NCT04025944 is actively recruiting participants. Contact the research team at yyq19890619@126.com for enrollment information.
Where is the NCT04025944 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04025944 clinical trial?
NCT04025944 is sponsored by Huashan Hospital. The principal investigator is Wenhong Zhang, Professor at Huashan Hospital. The trial plans to enroll 10,000 participants.